IFS (Nb/%) | Total | Ρ value | |||
---|---|---|---|---|---|
+ | – | ||||
Gender* | Male | 72 (63.2%) | 42 (36.8%) | 114 | 0.01 |
Female | 34 (85%) | 6 (15%) | 40 | ||
Status | Acute | 48 (70.6%) | 20 (29.4%) | 68 | 0.676 |
Chronic | 58 (67.4%) | 28 (32.6%) | 86 | ||
Treatment | Treated | 90 (68.7%) | 41 (31.3%) | 131 | 0.934 |
Untreated | 16 (69.9%) | 7 (30.4%) | 23 | ||
Therapy regimen#Δ | Routine | 31 (79.5%) | 8 (20.5%) | 39 | 0.088 |
Addition | 44 (63.8%) | 25 (36.2%) | 69 | ||
Mean age | 43.4 ± 13.5 | 43.9 (68.8%) | 42.2 (31.2%) | 154 | 0.472 |